Predictmedix AI arranges $900,000 private placement

Executive Summary

• Predictmedix AI Inc. announced a non-brokered private placement to raise up to $900,000 by issuing up to 18 million units at $0.05 per unit.
• The capital will be used to strengthen the company's core AI technology, support product ecosystem initiatives, and maintain public company operations and regulatory compliance.
• The offering includes warrants exercisable at $0.15 per half-share, with an acceleration clause tied to the stock price reaching $0.30 for 10 consecutive days.

Key Details

• Transaction Structure: Non-brokered private placement.
• Units Issued: Up to 18,000,000 units.
• Price Per Unit: $0.05.
• Gross Proceeds: Up to $900,000.
• Warrant Terms: Each unit includes one-half (0.5) of a common share purchase warrant.
• Warrant Exercise Price: $0.15 per half-share (effectively $0.30 per full share).
• Warrant Duration: 36 months following the closing date.
• Acceleration Clause: If the volume-weighted average price (VWAP) of common shares on the Canadian Securities Exchange is $\ge$ $0.30 for any 10 consecutive trading days (starting 4 months and 1 day after closing), the company may accelerate the warrant expiry to 30 days after written notice.
• Use of Proceeds: Strengthening core AI technology, advancing the Predictmedix core AI engine, and supporting growth verticals including AI-powered clinical trial applications, SmartHealth AI station certification, and B2C vital-scanning mobile platform development.
• Recent Activity: The company participated in the 25th MK Investment Conference in Munich, engaging with global investors and partners.

Notable Quotes

• "The investor engagement and strategic discussions in Munich validated the global relevance of our AI technology. This financing provides additional flexibility as we continue to strengthen our platform, explore new partnerships and scale commercialization opportunities." — Dr. Rahul Kushwah, Chief Operating Officer